伊朗耐利福平结核病：一项系统评价与荟萃分析 - Suppr

Rifampicin-resistant tuberculosis in Iran: A systematic review and meta-analysis.

作者信息

Bahraminia Farhad, Azimi Taher, Zangiabadian Moein, Nasiri Mohammad Javad, Goudarzi Mehdi, Dadashi Masoud, Imani Fooladi Abbas Ali

机构信息

Applied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Iran J Basic Med Sci. 2021 Jun;24(6):720-725. doi: 10.22038/ijbms.2021.47360.10901.

DOI:10.22038/ijbms.2021.47360.10901

PMID:34630948

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8487596/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c51/8487596/e70e19069399/IJBMS-24-720-g001.jpg

相似文献

Rifampicin-resistant tuberculosis in Iran: A systematic review and meta-analysis.伊朗耐利福平结核病：一项系统评价与荟萃分析

Iran J Basic Med Sci. 2021 Jun;24(6):720-725. doi: 10.22038/ijbms.2021.47360.10901.

Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert® MTB/RIF in Kampala, Uganda: a retrospective study.使用 Xpert® MTB/RIF 在乌干达坎帕拉检测结核分枝杆菌临床分离株中 rpoB 基因 81bpRRDR 区的利福平耐药突变：一项回顾性研究。

BMC Infect Dis. 2014 Sep 4;14:481. doi: 10.1186/1471-2334-14-481.

An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIF.对Xpert MTB/RIF检测利福平耐药假阳性的评估。

Mem Inst Oswaldo Cruz. 2017 Nov;112(11):756-759. doi: 10.1590/0074-02760170051.

Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study.在巴基斯坦开伯尔-普赫图赫瓦省使用Xpert MTB/RIF检测结核分枝杆菌临床分离株rpoB基因81bp利福平耐药决定区的利福平耐药突变：一项回顾性研究

BMC Infect Dis. 2016 Aug 12;16:413. doi: 10.1186/s12879-016-1745-2.

Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms.Xpert MTB/RIF 和 Xpert Ultra 检测用于筛查成人肺结核和利福平耐药，无论有无症状。

Cochrane Database Syst Rev. 2021 Mar 23;3(3):CD013694. doi: 10.1002/14651858.CD013694.pub2.

Rifampicin resistance in in Iran: a two-centre study.伊朗的利福平耐药性：一项双中心研究。

New Microbes New Infect. 2021 Jun 23;42:100909. doi: 10.1016/j.nmni.2021.100909. eCollection 2021 Jul.

Xpert MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance.用于肺外结核病和利福平耐药性的Xpert MTB/RIF检测

Cochrane Database Syst Rev. 2018 Aug 27;8(8):CD012768. doi: 10.1002/14651858.CD012768.pub2.

Effect of Xpert MTB/RIF on the treatment of multi-drug-resistant or rifampicin-resistant tuberculosis screened out from re-treatment pulmonary tuberculosis patients, a prospective cohort study.Xpert MTB/RIF对从复治肺结核患者中筛查出的耐多药或利福平耐药结核病治疗效果的前瞻性队列研究。

Ann Palliat Med. 2020 Mar;9(2):239-246. doi: 10.21037/apm.2020.02.17. Epub 2020 Mar 17.

Assessing the utility of the Xpert Mycobacterium tuberculosis/rifampin assay for analysis of bronchoalveolar lavage fluid in patients with suspected pulmonary tuberculosis.评估 Xpert 分枝杆菌/利福平检测在疑似肺结核患者支气管肺泡灌洗液分析中的应用价值。

J Clin Lab Anal. 2022 Jan;36(1):e24154. doi: 10.1002/jcla.24154. Epub 2021 Dec 1.

Diagnosis of rifampicin-resistant tuberculosis: Discordant results by diagnostic methods.耐利福平结核病的诊断：不同诊断方法结果不一致

Afr J Lab Med. 2018 Dec 6;7(2):806. doi: 10.4102/ajlm.v7i2.806. eCollection 2018.

引用本文的文献

Prevalence and contributing factors of drug-resistant tuberculosis (DR-TB) in iran: a systematic review.伊朗耐多药结核病（DR-TB）的患病率及影响因素：一项系统评价

BMC Infect Dis. 2025 Aug 8;25(1):1004. doi: 10.1186/s12879-025-11439-8.

Bayesian estimation of the time-varying reproduction number for pulmonary tuberculosis in Iran: A registry-based study from 2018 to 2022 using new smear-positive cases.伊朗肺结核随时间变化的繁殖数的贝叶斯估计：一项基于登记处的研究，使用2018年至2022年新涂片阳性病例。

Infect Dis Model. 2024 May 10;9(3):963-974. doi: 10.1016/j.idm.2024.05.003. eCollection 2024 Sep.

Prevalence of rifampicin resistant pulmonary tuberculosis using geneXpert assay in Ethiopia, a systematic review and meta-analysis.在埃塞俄比亚使用GeneXpert检测法检测耐利福平肺结核的患病率：一项系统评价与荟萃分析

Heliyon. 2023 Aug 28;9(9):e19554. doi: 10.1016/j.heliyon.2023.e19554. eCollection 2023 Sep.

Overcoming through small molecule inhibitors to break down cell wall synthesis.通过小分子抑制剂克服以破坏细胞壁合成。

Acta Pharm Sin B. 2022 Aug;12(8):3201-3214. doi: 10.1016/j.apsb.2022.04.014. Epub 2022 Apr 27.

本文引用的文献

Management of rifampicin-resistant TB: programme indicators and care cascade analysis in South Africa.利福平耐药结核病管理：南非的规划指标和关怀级联分析。

Int J Tuberc Lung Dis. 2021 Feb 1;25(2):134-141. doi: 10.5588/ijtld.20.0598.

Rifampicin Mono-Resistant Tuberculosis-A Review of an Uncommon But Growing Challenge for Global Tuberculosis Control.耐利福平肺结核——对全球结核病控制而言，一种虽不常见但日益严峻的挑战之综述

Open Forum Infect Dis. 2021 Jan 28;8(2):ofab018. doi: 10.1093/ofid/ofab018. eCollection 2021 Feb.

Clinical perspectives on treatment of rifampicin-resistant/multidrug-resistant TB.耐利福平/耐多药结核病治疗的临床观点。

Int J Tuberc Lung Dis. 2020 Nov 1;24(11):1134-1144. doi: 10.5588/ijtld.20.0330.

Risk factors for poor treatment outcomes of 2266 multidrug-resistant tuberculosis cases in Ho Chi Minh City: a retrospective study.胡志明市 2266 例耐多药结核病治疗结局不良的危险因素：一项回顾性研究。

BMC Infect Dis. 2020 Feb 22;20(1):164. doi: 10.1186/s12879-020-4887-1.

MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network.耐多药/广泛耐药结核病患者和接触者的管理：新十年面临的挑战。全球结核病网络 2020 年临床更新。

Int J Infect Dis. 2020 Mar;92S:S15-S25. doi: 10.1016/j.ijid.2020.01.042. Epub 2020 Feb 4.

Low diagnostic accuracy of Xpert MTB/RIF assay for extrapulmonary tuberculosis: A multicenter surveillance.Xpert MTB/RIF assay 对肺外结核的诊断准确性低：一项多中心监测。

Sci Rep. 2019 Dec 6;9(1):18515. doi: 10.1038/s41598-019-55112-y.

Direct drug susceptibility testing of Mycobacterium tuberculosis using the proportional method: A multicenter study.采用比例法对结核分枝杆菌进行直接药物敏感性检测：一项多中心研究。

J Glob Antimicrob Resist. 2019 Jun;17:242-244. doi: 10.1016/j.jgar.2018.12.022. Epub 2019 Jan 7.

Molecular detection of rifampin, isoniazid, and ofloxacin resistance in Iranian isolates of by high-resolution melting analysis.通过高分辨率熔解分析对伊朗分枝杆菌分离株中利福平、异烟肼和氧氟沙星耐药性的分子检测。

Infect Drug Resist. 2018 Oct 18;11:1819-1829. doi: 10.2147/IDR.S178831. eCollection 2018.

Prevalence of tuberculosis and multidrug resistant tuberculosis in the Middle East Region.中东地区的结核病和耐多药结核病流行情况。

Expert Rev Anti Infect Ther. 2018 Sep;16(9):709-721. doi: 10.1080/14787210.2018.1519393. Epub 2018 Sep 13.

Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment.耐药性结核病：诊断和治疗的挑战与机遇。

Curr Opin Pharmacol. 2018 Oct;42:7-15. doi: 10.1016/j.coph.2018.05.013. Epub 2018 Jun 6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Rifampicin-resistant tuberculosis in Iran: A systematic review and meta-analysis.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献